What is the recommended dosing and length of therapy for cefepime (Cefepime) in a paraplegic patient with a suprapubic catheter (suprapubic cath), normal renal function, and E. coli bacteremia, who is also growing E. coli in their urine, with resistance to cefazolin (Cefazolin), ceftriaxone (Ceftriaxone), and trimethoprim/sulfamethoxazole (Bactrim), but sensitive to cefepime (Cefepime)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefepime Dosing and Duration for E. coli Bacteremia in a Paraplegic Patient with Suprapubic Catheter

For this paraplegic patient with E. coli bacteremia and catheter-associated UTI with normal renal function, administer cefepime 2 g IV every 8 hours for 14 days, and replace the suprapubic catheter as soon as feasible.

Dosing Regimen

Cefepime 2 g IV every 8 hours is the appropriate dose for severe complicated urinary tract infections and bacteremia. 1

  • The FDA-approved dosing for severe complicated UTI due to E. coli is 2 g IV every 12 hours, but for bacteremia with a urinary source in a catheterized patient, the more aggressive every-8-hour regimen is warranted 1
  • Standard dosing of 1-2 g every 12 hours may be inadequate for bacteremia, particularly when the MIC approaches 8 μg/mL, as mortality rates increase significantly at this threshold 2
  • Patients with bacteremia due to gram-negative organisms treated with cefepime at MIC ≥8 μg/mL had a mortality rate of 54.8%, compared to 24.1% for MIC <8 μg/mL 2
  • The every-8-hour dosing provides superior pharmacodynamic target attainment for serious bloodstream infections 2

Duration of Therapy

Treat for 14 days total from the first negative blood culture, assuming the suprapubic catheter is replaced and blood cultures clear within 72 hours. 3

  • For catheter-associated bacteremia with a retained or delayed catheter change, 14 days is the standard duration for uncomplicated gram-negative bacteremia 3
  • If bacteremia persists >72 hours after catheter removal or appropriate therapy initiation, extend treatment to 4-6 weeks due to concern for endovascular infection or metastatic complications 3
  • The 7-10 day duration listed in the FDA label applies to uncomplicated UTI without bacteremia; bacteremia requires longer treatment 1

Critical Management Steps

Catheter Management

The suprapubic catheter must be replaced as soon as possible—ideally within 24-48 hours of starting antibiotics. 3, 4

  • Retained infected catheters serve as a nidus for persistent bacteremia and biofilm formation 3
  • In spinal cord injury patients with long-term catheters and bacteremia, catheter retention is associated with treatment failure and recurrent infection 3
  • Do not wait indefinitely for catheter change—coordinate urgent replacement even if it requires procedural scheduling 4

Monitoring for Treatment Response

Obtain repeat blood cultures 48-72 hours after starting cefepime to document clearance of bacteremia. 3

  • Persistent positive blood cultures at 72 hours indicate complicated infection requiring extended therapy (4-6 weeks) 3
  • Monitor for clinical improvement: defervescence within 48-72 hours, resolution of hemodynamic instability, and improved mental status 3
  • If fever or positive blood cultures persist beyond 72 hours despite appropriate antibiotics and catheter change, investigate for metastatic complications including endocarditis, epidural abscess, or suppurative thrombophlebitis 3

Special Considerations for Paraplegic Patients

Asymptomatic Bacteriuria vs. True Infection

  • This patient has true symptomatic infection (bacteremia), not asymptomatic bacteriuria, so treatment is absolutely indicated 3, 4
  • Asymptomatic bacteriuria is nearly universal in patients with long-term suprapubic catheters (approaching 100% prevalence) and should not be treated 3, 4
  • The presence of bacteremia distinguishes this case from asymptomatic colonization and mandates aggressive treatment 3

Renal Function Monitoring

  • Verify normal renal function with creatinine clearance calculation before using standard dosing 1
  • If creatinine clearance is 30-60 mL/min, reduce to 2 g every 12 hours; if 11-29 mL/min, reduce to 1 g every 24 hours 1
  • Paraplegic patients may have reduced muscle mass affecting creatinine-based estimates, so consider cystatin C if available 1

Common Pitfalls to Avoid

Do not use the 7-10 day duration listed for uncomplicated UTI—this patient has bacteremia requiring 14 days minimum. 3, 1

Do not delay catheter replacement waiting for "sterile urine"—the catheter itself perpetuates infection and must be changed during treatment. 3, 4

Do not assume clinical improvement means adequate treatment—document negative blood cultures before shortening therapy. 3

Do not use cefepime 1 g every 12 hours for bacteremia—this dosing is inadequate and associated with treatment failure. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment for Afebrile Males with Suprapubic Tubes After Tube Change

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What should be recorded as the primary cause of death for an elderly patient with a history of ischemic heart disease (IHD) who underwent coronary artery bypass grafting (CABG) and developed septicemia due to a surgical site infection, leading to multiorgan failure?
What is the best treatment for bladder spasms occluding a Foley (urinary) catheter?
What is the management for a patient with a suprapubic (urinary catheter inserted through the abdomen) catheter presenting with hematuria (blood in urine)?
Can a Foley catheter cause bladder spasms?
What is the next step in managing a 54-year-old woman with postoperative urinary retention following retropubic sling surgery, who has suprapubic pain, abdominal fullness, and a urethral catheter with low return on irrigation?
What is the recommended treatment approach for a patient with renal cell carcinoma?
What is the best course of action for a 22-year-old female patient with a 2.7 x 1.6 cm inguinal lymph node (lymph node) with mild heterogeneous cortex and preserved fatty hilum (hilum) with hypervascularity, no history of cancer, and a new lymph node behind her ear that is small, soft, movable, but becoming firm and growing, without any reactive symptoms?
What is the appropriate management for a patient with no significant medical history, presenting with a rapidly enlarging inguinal lymph node that grew from a pea to a large grape size within a few days, and a smaller lymph node behind the ear, approximately half a pea in size?
What are the primary biochemical abnormalities in a patient with Addison's disease?
What is the recommended dose of hydromorphone (Dilaudid) for a patient with impaired renal function?
What is the Milwaukee protocol for treating rabies exposure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.